Abstract
Companies increasingly seek to strategically integrate social objectives in commercial activities to address societal challenges, yet little is known about how companies can sustain such a commitment over time. To address this question, we conduct a case-based, abductive study of two pharmaceutical companies widely considered industry leaders in facilitating access to medicine over a 20-year period (2000–2019). We identify product and operation-level integration as distinct types of integration efforts enacted by these companies. Tracing the intraorganizational dynamics associated with these efforts, we theorize that sustained integration is contingent on companies’ ability to respond to and address the challenges specific to product and operation-level integration. The theoretical framework we develop contributes to an emerging debate on the potential of companies to make progress on societal challenges by strategically integrating social objectives, including but not limited to those related to global health.
| Original language | English |
|---|---|
| Pages (from-to) | 1110–1148 |
| Number of pages | 39 |
| Journal | Business & Society |
| Volume | 63 |
| Issue number | 5 |
| Early online date | 2023 |
| DOIs | |
| Publication status | Published - 2024 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
-
SDG 12 Responsible Consumption and Production
Keywords
- access to medicine
- corporate responsibility
- integration of social objectives
- pharmaceutical industry
Fingerprint
Dive into the research topics of 'Sustaining the integration of social objectives over time: A case-based analysis of access to medicine in the pharmaceutical industry'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver